Proiezione Più S.r.l., founded in 1991, operates in the field of single-dose packaging in heat-sealed bags, covering a total area of more than 2,500 square meters. It has various packaging sectors and state-of-the-art, advanced technology machines for bags containing medical and surgical devices, medical devices, cosmetics and food supplements.

D.M.G. Italia S.r.l. is a company engaged in the development of innovative medical devices, using proprietary formulations and participating in research and development, production and marketing. The therapeutic areas of greatest interest are gastroenterology, otolaryngology, pediatrics, ophthalmology, orthopedics and stomatology.

Thanks to the integration of Proiezione Più, D.M.G. aims to expand and diversify its portfolio of services.

Cross Border, drawing on a team with specific expertise in the CDMO sector, acted as exclusive advisor to the seller, managing the entire sale process and contacting more than 50 domestic and foreign counterparties.

After an initial screening phase, Cross Border selected a shortlist of potential investors and assisted the client in structuring the transaction, conducting due diligence and negotiating. This transaction is part of a market consolidation process involving numerous industrial and financial operators, selected on the basis of both their economic capacity and their focus on the target’s business continuity.